Janethe de Oliveira Pena

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 7

Top Topics

Polycyclic Aromatic Hydrocarbons

Pulmonary Arterial Hypertension

Top Venues

CPT: pharmacometrics & systems pharmacology

Circulation. Heart failure

This page only lists publications with an associated author ORCID identifier.

Publications

Sihem Ait-Oudhia, David Jaworowicz, Ziheng Hu, Sébastien Bihorel, Shuai Hu, Budda Balasubrahmanyam, Bipin Mistry, Janethe de Oliveira Pena, Larissa Wenning, Ferdous Gheyas
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Aaron B Waxman, David M Systrom, Solaiappan Manimaran, Janethe de Oliveira Pena, Jonathan Lu, Franz P Rischard
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension. Circulation. Heart failure 17 (5) (2024)
Sihem Ait-Oudhia, David Jaworowicz, Ziheng Hu, Sébastien Bihorel, Shuai Hu, Budda Balasubrahmanyam, Bipin Mistry, Janethe de Oliveira Pena, Larissa Wenning, Ferdous Gheyas
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)
Sihem Ait-Oudhia, David Jaworowicz, Ziheng Hu, Sébastien Bihorel, Shuai Hu, Budda Balasubrahmanyam, Bipin Mistry, Janethe de Oliveira Pena, Larissa Wenning, Ferdous Gheyas
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension. CPT: pharmacometrics & systems pharmacology (2024)
Aaron B Waxman, David M Systrom, Solaiappan Manimaran, Janethe de Oliveira Pena, Jonathan Lu, Franz P Rischard
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension. Circulation. Heart failure (2024)
Aaron B Waxman, David M Systrom, Solaiappan Manimaran, Janethe de Oliveira Pena, Jonathan Lu, Franz P Rischard
SPECTRA Phase 2b Study: Impact of Sotatercept on Exercise Tolerance and Right Ventricular Function in Pulmonary Arterial Hypertension. Circulation. Heart failure 17 (5) (2024)
Sihem Ait-Oudhia, David Jaworowicz, Ziheng Hu, Sébastien Bihorel, Shuai Hu, Budda Balasubrahmanyam, Bipin Mistry, Janethe de Oliveira Pena, Larissa Wenning, Ferdous Gheyas
Population pharmacokinetic modeling of sotatercept in healthy participants and patients with pulmonary arterial hypertension. CPT: pharmacometrics & systems pharmacology 13 (8) (2024)